Antares Pharma is stepping up its pursuit of Pfizer. Having taken a rescue pen rival to Pfizer’s Solu-Cortef through a phase 1 study, Antares is preparing for a pivotal clinical trial designed to ...

Study met primary end point and demonstrated successful subcutaneous administration of a 10 mL biologic co-formulated with ENHANZE® in 30 seconds using Halozyme's proprietary high-volume auto-injector ...